Plain-English translation of NCT07588932 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Stroke research guide โPhase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This trial is testing whether a combination of three medications โ Telmisartan, Cilostazol IR, and Metformin ER โ can help stroke survivors gain more arm strength and movement when used together with robotic upper-arm rehabilitation therapy. The medications are designed to improve blood flow and support healing, while the robotic device helps you practice arm movements in a controlled way. Researchers want to see if this combination approach works better than robotic therapy alone.
Many stroke survivors struggle to regain full arm function even after rehabilitation. This medication combination has properties that might support brain healing and improve blood flow, so researchers want to test whether pairing it with robotic therapy could help people recover better arm control and function.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would take the three medications by mouth once or twice daily as directed, while attending robotic upper-arm rehabilitation sessions over several weeks. During visits, you'll work with a robotic device that guides your arm through exercises and games on a screen to help rebuild strength and movement. The study team will check your progress, monitor for any side effects, and take blood samples at key points to measure how your body is responding.
AI-generated summary from trial data ยท Aug 15, 2026 ยท Not medical advice
United States